Korea’s Green Cross Anticipates Growth In Upcoming Flu Season
This article was originally published in PharmAsia News
Executive Summary
The upcoming flu season should provide more momentum to Korea’s leading vaccine company, which saw marginal year-on-year growth in the second quarter.